Data

A Randomised Phase II study comparing the efficacy of 5azacitidine alone versus combination therapy with lenalidomide and 5azacitidine in patients with higher risk myelodysplastic syndromes (MDS) and low marrow blast count acute myeloid leukaemia (AML). (MDS04)

Health Data Australia Contributor Records

Kenealy, Melita ; Australasian Leukaemia And Lymphoma Group (ALLG) ; Australasian Leukaemia And Lymphoma Group (ALLG)

Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]

ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.58109/E8XK-3G33&rft.title=A Randomised Phase II study comparing the efficacy of 5azacitidine alone versus combination therapy with lenalidomide and 5azacitidine in patients with higher risk myelodysplastic syndromes (MDS) and low marrow blast count acute myeloid leukaemia (AML). (MDS04)&rft.identifier=http://doi.org/10.58109/E8XK-3G33&rft.publisher=Australasian Leukaemia and Lymphoma Group (ALLG)&rft.description=Dataset includes: Data for 160 patients with newly diagnosed MDS. Patients were randomised to receive lenalidomide and 5azacitidine or 5azacitidine alone Demographic data, diagnostic data, treatment data, outcome data and measures of supportive care during treatment, Eg transfusion requirements, QoL&rft.creator=Kenealy, Melita &rft.creator=Australasian Leukaemia And Lymphoma Group (ALLG) &rft.creator=Australasian Leukaemia And Lymphoma Group (ALLG) &rft.date=2023&rft.relation=https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12610000271000&rft_subject=Chemotherapy&rft.type=dataset&rft.language=English Access data via landing page

Cite Saved to MyRDA Save to MyRDA

Full description

Dataset includes: Data for 160 patients with newly diagnosed MDS. Patients were randomised to receive lenalidomide and 5azacitidine or 5azacitidine alone Demographic data, diagnostic data, treatment data, outcome data and measures of supportive care during treatment, Eg transfusion requirements, QoL

Notes

HeSANDA 1.0.0

Issued: 2023

This dataset is part of a larger collection

Click to explore relationships graph

Subjects

Chemotherapy |

User Contributed Tags

Login to tag this record with meaningful keywords to make it easier to discover

Other Information

Azacitidine with or without lenalidomide in higher risk myelodysplastic syndrome & low blast acute myeloid leukemia

doi : http://doi.org/10.3324/haematol.2018.201152 DOI Link

Australasian Leukaemia And Lymphoma Group (ALLG)

ROR : https://ror.org/05t72y326

Australasian Leukaemia and Lymphoma Group (ALLG)

ROR : https://ror.org/05t72y326

Identifiers

DOI : 10.58109/E8XK-3G33